Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways

• Main Authors: Fei Zhou (Author), Mingning Ding (Author), Yiqing Gu (Author), Guifang Fan (Author), Chuanyang Liu (Author), Yijie Li (Author), Rong Sun (Author), Jianzhi Wu (Author), Jianchao Li (Author), Xiaoyong Xue (Author), Hongjuan Li (Author), Xiaojiaoyang Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Nonalcoholic fatty liver disease (NAFLD), manifested as the aberrant accumulation of lipids in hepatocytes and inflammation, has become an important cause of advanced liver diseases and hepatic malignancies worldwide. However, no effective therapy has been approved yet. Aurantio-obtusin (AO) is a ma...